pituitary Flashcards

growth hormone deficiency: list the endocrine and non-endocrine causes of short stature, explain how a diagnosis of endocrine short stature is made, recall the pharmacodynamic and pharmacokinetic properties of human growth hormone and the rationale governing its use

1
Q

replacement and check if GH deficient

A

GH; IGF1, growth chart (children)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

other name of growth hormone

A

somatotrophin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

effect of GH deficiency in children

A

short stature (2 s.ds < mean height for that age and sex); can give GH if proved deficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

7 categories of short stature causes

A

genetic, emotional deprivation (stress axis), systemic disease, malnutrition, malabsorption, endocrine disorders, skeletal dysplasias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 genetic causes of short stature

A

Down’s syndrome, Turner’s syndrome, Prader Willi syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 systemic diseases causing short stature

A

cystic fibrosis, rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

malabsorption cause of short stature

A

coeliac disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 endocrine diseases causing short stature

A

Cushing’s syndrome (excess cortisol), hypothyroidism, GH deficiency, poorly controlled type 1 diabetes mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 skeletal dysplasias causing short stature

A

achondroplasia, osteogenesis imperfecta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

growth axis of somatotrophin

A

hypothalamus -> GHRH (inhibited by somatostatin) -> adenohyphysis -> somatotrophin -> direct: target tissues; indirect: liver -> release of IGFI (and IGFII) -> target tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

growth axis: where does Prader Willi syndrome affect

A

hypothalamus, so GHRH and consequently GH deficiency; secondary to hypothalamic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

growth axis: cause of short stature due to pituitary dwarfism

A

lack of somatotrophin released

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

growth axis: cause of Laron dwarfism

A

GH receptor defect in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

dwarfism: achondroplasia: mutation

A

mutation in fibroblast growth factor receptor 3 (FGF3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dwarfism: achondroplasia: what causes impaired linear growth

A

abnormality in growth plate chondrocytes so skeletal issue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

dwarfism: achondroplasia: clinical presentation

A

average trunk size, short limbs

17
Q

dwarfism: pituitary

A

childhood GH deficiency

18
Q

dwarfism: Laron dwarfism: mutation and treatment

A

mutation in GH receptor; treated with IGF1 in childhood to increase height

19
Q

diagnosis of short stature: mid-parental height

A

predicted adult height based on father’s and mother’s height

20
Q

diagnosis of short stature: monitoring height

A

drop of more than 2 centiles is flagged and investigated (e.g. coeliac disease so gluten-free diet then continues to grow at normal rate)

21
Q

4 causes of acquired GH deficiency in adults, and what they affect

A

trauma, pituitary tumour, pituitary surgery, cranial radiotherapy; all affect region before reaching liver or target tissues (secondary disease)

22
Q

how is GH deficiency diagnosed in adults

A

as GH is pulsatile, random GH test is of little use; instead, provocative challenge (stimulation test)

23
Q

GH provocation tests: 4 factors and measurement

A

GHRH and arginine (may inhibit somatostatin release) injected (i.v.), insulin (promote hypoglycaemia) injected (i.v.), glucagon (causes secretion of ACTH and GH as causes vomiting, causing stress) injected (i.m.), exercise (e.g. 10 min step climbing when appropriate); measure plasma GH at specific points before and after

24
Q

GH secretion in response to hypoglycaemia (insulin tolerance test)

A

normally increases hugely upon IV insulin injection (above NICE cut-off of 3mcg/L), but if GH deficient then won’t reach cut-off so warrant treatment

25
Q

GH therapy preparation

A

human recombinant GH (somatotropin); not usually required in adults as finished growing

26
Q

GH therapy administration

A

daily, subcutaneous injection; monitor clinical response and adjust dose to IGF1

27
Q

4 signs and symptoms of GH deficiency in adults

A

reduced lean mass (increased adiposity and waist:hip ratio), reduced muscle strength and bulk (reduced exercise performance), decreased plasma HDL-cholesterol and raised LDL-cholesterol, impaired psychological well-being and reduced quality of life

28
Q

5 potential benefits of GH therapy in adults

A

improved body composition (reduced waist:hip ratio and less visceral fat), improved muscle strength, more favourable lipid profile (increased plasma HDL-cholesterol and decreased LDL-cholesterol), increased bone mineral density, improved psychological well-being and quality of life

29
Q

2 potential risks of GH therapy in adults

A

possibly increased susceptibility to cancer (helps cells to grow), expensive lifelong treatment

30
Q

what type of hormone is growth hormone

A

polypeptide (protein)

31
Q

are protein hormones absorbed well when given orally

A

no

32
Q

duration of action of protein vs steroid hormones

A

steroid hormones are longer acting (>24hrs)

33
Q

where do protein hormones act on

A

membrane-bound receptors